Is Venus Remedies Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Venus Remedies Ltd (VENUSREM.NS) is currently classified as NOT HALAL as of January 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Venus Remedies Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Venus Remedies Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Venus Remedies Ltd?

Muslim investors may consider investing in Venus Remedies Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Venus Remedies Ltd classified as NOT HALAL?

Musaffa determines the Shariah status of Venus Remedies Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Venus Remedies Ltd updated?

The Shariah compliance status of Venus Remedies Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Venus Remedies Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Venus Remedies Ltd?

You can check the latest Shariah compliance status of Venus Remedies Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

VENUSREM.NS Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: January 10, 2026

Report Source: 2026 2nd Quarter Report

Venus Remedies Ltd. Stock Analysis VENUSREM.NS

India Health Care Micro Cap Report: Q2, 2026

Venus Remedies Ltd. engages in the manufacture and trade of pharmaceutical products. The company is headquartered in Panchkula, Haryana and currently employs 1,298 full-time employees. The firm is a global injectable manufacturer. The company manufactures products catering to critical care segments such as antimicrobial resistance, anti-cancer, Anti-infective, Neurology, Skin and Wound Care, and Pain Management. With a diverse portfolio of products, the Company is dedicated to revolutionizing patient care through its specialized therapeutic segments such as anti-infective (antibiotics), oncology, neurology, pain management, and skin & wound care. The firm operates only in one business segment: Pharmaceutical Formulation and is engaged in manufacturing and trading of medicines. Its focus therapy areas include medicine, surgery, neuro and orthopedics. The Company’s brands include Potentox, Vancoplus Combi, Tobracef, Supime, Zydotum, Neurotol, Trois, Septiloc, Mucomelt, and others. The company has three manufacturing facilities: Panchkula and Baddi in India and Werne in Germany.

Key Statistics of Venus Remedies Ltd (VENUSREM.NS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹905.90₹941.75

Today's Open

₹937.70

Volume

24.86K

P/E Ratio (TTM)

27.58

52 Week Range

₹305.00₹1,088.80

Market Cap

13.08B

Avg. Volume

59.00K

Dividend Yield

Financial Metrics & Statements of Venus Remedies Ltd (VENUSREM.NS)

FAQ's for Venus Remedies Ltd (VENUSREM.NS)

According to Musaffa’s Shariah screening methodology, Venus Remedies Ltd (VENUSREM.NS) is currently classified as NOT HALAL as of January 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.